✦ LIBER ✦

Clinical observation of Fufangchangtai decoction combined with FOLFOX4 regimen for postoperative colorectal cancers

✍ Scribed by Lingchang Li; Mingzhi Fang; Xiaoning Wang; Jiege Huo

Book ID: 106315272
Publisher: Springer
Year: 2011
Tongue: English
Weight: 196 KB
Volume: 10
Category: Article
ISSN: 1610-1979
DOI: 10.1007/s10330-011-0764-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical observation of treatment with Y

Clinical observation of treatment with Yiqi Jianpi decoction combined with FOLFOX4 for the postoperation patients of colorectal cancer

✍ Cao, Bo; Den, Wenling 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 324 KB

The clinical observation of three-dimens

The clinical observation of three-dimensional conformal radiotherapy combined with FOLFOX chemotherapy for rectal cancer of postoperative local recurrence

✍ Zhou, Yeqin; Liu, Mi; Ma, Daiyuan; Ren, Tao; Ma, Xiaojie; Li, Xianfu; Tan, Bangx 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 295 KB

Clinical analysis of HCPT plus FOLFOX4 r

Clinical analysis of HCPT plus FOLFOX4 regimen as salvage therapy for patients with advanced gastric cancer

✍ Xiaoqiang Fan; Xijian Zhou; Xiangyong Li; Xinyu Tang; Rengui Zhou; Dejian Pan 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 74 KB

444 A phase I/II study of oblimersen sod

444 A phase I/II study of oblimersen sodium in combination with oxaliplatin, 5-FU and leucovorin (FOLFOX4 regimen) in patients with advanced colorectal cancer

✍ C. Mita; M. Goldston; J. Kuhn; M.J. Egorin; M. Beeram; A. Patnaik; M.M. Mita; J. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 154 KB

First clinical experience of orally acti

First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first-line treatment for metastatic colorectal cancer

✍ Maria Giulia Zampino; Elena Magni; Cristian Massacesi; Alberto Zaniboni; Angelo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 1 views

## Abstract ## BACKGROUND. Gefitinib, an orally active inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase, combined with chemotherapy, has shown efficacy as second‐line treatment for advanced colorectal cancer (CRC). Gefitinib combined with FOLFOX6 (oxaliplatin plus folinic acid

Treatment with Yiqi Bushen Koufuye Combi

Treatment with Yiqi Bushen Koufuye Combined with Chemotherapy for Preventing Postoperative Metastasis of Stomach Cancer — A Clinical Observation of 28 Cases

✍ Yun-xia LIU; Shen-jun JIANG; Tang-hong KUANG; Yong-wei YAO; Jie-wen YANG; Yi-qin 📂 Article 📅 2009 🏛 Elsevier ⚖ 180 KB